Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 1.83 USD Market Closed
Market Cap: 16.5m USD

Operating Margin

-94.3%
Current
Improving
by 17.4%
vs 3-y average of -111.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-94.3%
=
Operating Income
$-16.3m
/
Revenue
$17.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-94.3%
=
Operating Income
$-16.3m
/
Revenue
$17.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Vivos Therapeutics Inc
NASDAQ:VVOS
15.1m USD
Loading...
US
CVS Health Corp
NYSE:CVS
105B USD
Loading...
US
Cigna Corp
NYSE:CI
74.8B USD
Loading...
US
Cigna Group
XMUN:CGN
62.4B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.6B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.4B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.2B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.7B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.3B AUD
Loading...

Market Distribution

Lower than 85% of companies in the United States of America
Percentile
15th
Based on 14 112 companies
15th percentile
-94.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Vivos Therapeutics Inc
Glance View

Market Cap
16.5m USD
Industry
Health Care

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Highlands Ranch, Colorado and currently employs 158 full-time employees. The company went IPO on 2020-12-11. The firm is focused on the development and commercialization to dental practices of a patented oral appliance technology and related protocols called the Vivos System. The firm's Vivos System is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for people with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The Company’s business model is focused on dentists, and the Company’s program to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice (VIP) program. Its primary product used in the Vivos System is the mRNA appliance, a specifically designed, custom oral appliance that is worn primarily in the evening hours and overnight and is available for adults.

VVOS Intrinsic Value
2.06 USD
Undervaluation 11%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-94.3%
=
Operating Income
$-16.3m
/
Revenue
$17.3m
What is Vivos Therapeutics Inc's current Operating Margin?

The current Operating Margin for Vivos Therapeutics Inc is -94.3%, which is above its 3-year median of -111.7%.

How has Operating Margin changed over time?

Over the last 3 years, Vivos Therapeutics Inc’s Operating Margin has increased from -154.7% to -94.3%. During this period, it reached a low of -156.2% on Dec 31, 2022 and a high of -74.3% on Dec 31, 2024.

Back to Top